Current knowledge and management of vascular anomalies

Archives of Facial Plastic Surgery

Volumn 13, Issue 3, 2011, Pages 145-151

  Hochman, Marcelo ^a,b   Adams, Denise M ^a   Reeves, Travis D ^c  

^a Hemangioma International Treatment Center   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Cincinnati Children' s Hospital Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PROPRANOLOL;

DIFFERENTIAL DIAGNOSIS; HEMANGIOMA; HUMAN; INFANT; LOW LEVEL LASER THERAPY; REMISSION; REVIEW;

ADRENERGIC BETA-AGONISTS; DIAGNOSIS, DIFFERENTIAL; HEMANGIOMA; HUMANS; INFANT; LASER THERAPY; PROPRANOLOL; REMISSION, SPONTANEOUS;

EID: 80054038196     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfacial.2011.33     Document Type: Review

References (32)

1. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375-423.
2. Hassanein AH, Mulliken JB, Fishman SJ, Greene AK. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011;127 (1):347-351.
3. Marler JJ, Mulliken JB. Vascular anomalies: classification, diagnosis, and natural history. Facial Plast Surg Clin North Am. 2001;9(4):495-504.
4. Drolet BA, Swanson EA, Frieden IJ; Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr. 2008;153(5):712-715, 715, e1.
5. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138(12):1567-1576. (Pubitemid 35453469)
6. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, MihmMCJr. The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003;139(7):869-875. (Pubitemid 36898921)
7. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006;118(3):882-887. (Pubitemid 46091612)
8. Krol A, MacArthur CJ. Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. Arch Facial Plast Surg. 2005;7(5):307-311. (Pubitemid 43973813)
9. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001;137(5): 559-570. (Pubitemid 32458438)
10. Barnés CM, Christison-Lagay EA, Folkman J. The placenta theory and the origin of infantile hemangioma. Lymphat Res Biol. 2007;5(4):245-255.
11. Khan ZA, Boscolo E, Picard A, et al. Multipotential stem cells recapitulate human infantile hemangiomas in immunodefficient mice. J Clin Invest. 2008;118(7): 2592-2599. (Pubitemid 351949786)
12. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med. 2000;343 (3):185-189. (Pubitemid 30489216)
13. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr. 1997;130(4):631-640. (Pubitemid 27492656)
14. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18(6):894-900. (Pubitemid 14175292)
15. Williams EF III, Hochman M, Rodgers BJ, Brockbank D, Shannon L, Lam SM. A psychological profile of children with hemangiomas and their families. Arch Facial Plast Surg. 2003;5(3):229-234.
16. Batniji RK, Buckingham ED, Williams EF III. An aesthetic approach to facial hemangiomas. Arch Facial Plast Surg. 2005;7(5):301-306. (Pubitemid 43973812)
17. Burns AJ, Navarro JA, Cooner RD. Classification of vascular anomalies and the comprehensive treatment of hemangiomas. Plast Reconstr Surg. 2009;124 (1)(suppl):69e-81e.
18. Burns AJ, Navarro JA. Role of laser therapy in pediatric patients. Plast Reconstr Surg. 2009;124(1)(suppl):82e-92e.
19. Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet. 2002;360(9332):521-527. (Pubitemid 35232105)
20. Thomas RF, Hornung RL, Manning SC, Perkins JA. Hemangiomas of infancy: treatment of ulceration in the head and neck. Arch Facial Plast Surg. 2005; 7(5):312-315. (Pubitemid 43973814)
21. Adams DM. The nonsurgical management of vascular lesions. Facial Plast Surg Clin North Am. 2001;9(4):601-608.
22. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001;137(9):1208-1213. (Pubitemid 32847844)
23. Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med. 2010;362(11):1005-1013.
24. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104(6): 1616-1623. (Pubitemid 29510480)
25. Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas [published online February 16, 2011]. Int J Pediatr Otorhinolaryngol. doi:10.1016/j.ijporl.2011.01.028.
26. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol. 2010;163(2):269-274.
27. Zvulunov A, McCuaig C, Frieden IJ. Oral propranolol therapy for infantile hemangiomas beyond the proliferative phase: a multicenter retrospective study. Pediatr Dermatol. 2011;10(1111):1525-1470.
28. Hochman M, Williams EF III. Management of cutaneous hemangiomas. Facial Plast Surg Clin North Am. 2001;9(4):621-628.
29. Kulbersh J, Hochman M. Serial excision of facial hemangiomas. Arch Facial Plast Surg. 2011;13(3):199-202.
30. Waner M, Kastenbaum J, Scherer K. Hemangiomas of the nose: surgical management using a modified subunit approach. Arch Facial Plast Surg. 2008; 10(5):329-334.
31. Hochman M, Mascareno A. Management of nasal hemangiomas. Arch Facial Plast Surg. 2005;7(5):295-300. (Pubitemid 43973811)
32. Warren SM, Longaker MT, Zide BM. The subunit approach to nasal tip hemangiomas. Plast Reconstr Surg. 2002;109(1):25-30. (Pubitemid 34056652)